Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.1230
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM
0.1145
-0.0085 (-6.91%)
After-hours: Apr 17, 2025, 4:47 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $5.01 million as of April 17, 2025. Its market cap has decreased by -85.21% in one year.
Market Cap
5.01M
Enterprise Value
-30.98M
1-Year Change
-85.21%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $5.01M, a decrease of -98.50%. That is a compound annual growth rate of -60.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 5.01M | -71.10% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 68.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.83B |
| UnitedHealth Group | 541.80B |
| Johnson & Johnson | 372.56B |
| AbbVie | 306.67B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 231.96B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |